Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Safety needle firm Bio-Plexus reaps benefits from investment

This article was originally published in Clinica

Executive Summary

The Cooper Companies' women's healthcare business CooperSurgical saw its third-quarter revenues rise 30% to $20m, up 23% in the year to date. During the quarter, the company decided to phase out its Cerveillance colposcopy system, largely because the company has chosen to consolidate its colposcopy development into Leise Medical, which it bought 2000 and which claims a world leadership position in colposcopy. In May, CooperSurgical bought private infertility company Ackrad Laboratories for $12m.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT068089

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel